Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21,528	22,121	18,246	19,473	11,199	9,068
Market Cap Growth	0.20%	21.24%	-6.30%	73.88%	23.50%	9.97%
Enterprise Value	21,347	20,903	16,178	17,504	9,587	7,890
Last Close Price	32.09	32.36	27.39	28.89	15.90	12.37
PE Ratio	26.53	22.42	21.17	25.32	16.92	14.50
Forward PE	21.76	22.87	22.87	22.87	16.30	15.49
PS Ratio	3.08	2.69	2.21	2.82	1.70	1.30
PB Ratio	3.85	3.33	2.78	2.99	1.88	1.64
P/TBV Ratio	3.90	3.56	2.96	3.16	2.00	1.74
P/FCF Ratio	23.81	40.40	32.05	28.00	23.22	31.28
P/OCF Ratio	20.09	32.13	26.94	22.84	16.68	18.30
EV/Sales Ratio	2.66	2.54	1.96	2.53	1.45	1.13
EV/EBITDA Ratio	23.02	22.63	20.58	24.96	14.51	12.62
EV/EBIT Ratio	26.79	26.15	24.10	29.82	17.40	14.94
EV/FCF Ratio	20.57	38.17	28.42	25.17	19.88	27.22
Debt / Equity Ratio	0.20	0.05	0.04	0.01	0.01	0.01
Debt / EBITDA Ratio	1.38	0.37	0.34	0.06	0.06	0.07
Debt / FCF Ratio	1.24	0.62	0.47	0.06	0.09	0.15
Asset Turnover	0.76	0.81	0.86	0.80	0.82	0.94
Inventory Turnover	2.60	3.09	3.38	2.76	2.61	2.79
Quick Ratio	1.05	1.51	1.71	1.81	1.85	1.54
Current Ratio	1.70	2.03	2.17	2.64	2.59	2.38
Return on Equity (ROE)	14.18%	14.68%	13.37%	12.63%	11.85%	12.01%
Return on Assets (ROA)	4.69%	4.90%	4.37%	4.23%	4.27%	4.42%
Return on Capital (ROIC)	6.63%	7.24%	6.27%	5.85%	5.96%	6.07%
Earnings Yield	3.77%	4.46%	4.72%	3.95%	5.91%	6.90%
FCF Yield	4.20%	2.48%	3.12%	3.57%	4.31%	3.20%
Dividend Yield	3.99%	3.96%	4.09%	1.73%	1.89%	2.43%
Payout Ratio	106.14%	88.91%	44.96%	30.17%	35.15%	27.71%
Buyback Yield / Dilution	0.51%	0.71%	-0.94%	0.04%	0.37%	-0.37%
Total Shareholder Return	4.50%	4.67%	3.15%	1.77%	2.26%	2.05%

Source: S&P Capital IQ. Standard template. Financial Sources.